Issue navigation
Volume 17, Issue 2, 1 February 2011
Original Articles
Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 491–502, https://doi.org/10.1002/ibd.21384
Modulation of neutrophil motility by curcumin: Implications for inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 503–515, https://doi.org/10.1002/ibd.21391
Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 516–523, https://doi.org/10.1002/ibd.21361
Intestinal ferroportin expression in pediatric Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 524–531, https://doi.org/10.1002/ibd.21367
Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 532–542, https://doi.org/10.1002/ibd.21377
Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 543–556, https://doi.org/10.1002/ibd.21381
Seroreactivity against glycolytic enzymes in inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 557–564, https://doi.org/10.1002/ibd.21388
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 565–572, https://doi.org/10.1002/ibd.21330
Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: Good safety profile but lack of efficacy
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 573–582, https://doi.org/10.1002/ibd.21345
Gracilis muscle transposition for complex fistula and persistent nonhealing sinus in perianal Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 583–589, https://doi.org/10.1002/ibd.21311
Information needs and preferences of recently diagnosed patients with inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 590–598, https://doi.org/10.1002/ibd.21363
Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 599–604, https://doi.org/10.1002/ibd.21310
Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet's disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 605–613, https://doi.org/10.1002/ibd.21313
The role of self-efficacy in inflammatory bowel disease management: Preliminary validation of a disease-specific measure
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 614–620, https://doi.org/10.1002/ibd.21314
Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 621–632, https://doi.org/10.1002/ibd.21346
Physician density and hospitalization for inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 633–638, https://doi.org/10.1002/ibd.21357
Proceeding
IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 - Inflammatory bowel disease task force meeting
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 639–644, https://doi.org/10.1002/ibd.21409
Basic Science Review
Intestinal tissue kallikrein-kinin system in inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 645–654, https://doi.org/10.1002/ibd.21337
Clinical Review
Use of complementary and alternative medicine by patients with inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 655–662, https://doi.org/10.1002/ibd.21360
Selected Summaries
Breastfeeding in inflammatory bowel disease: Positive results for mother and child
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 663–664, https://doi.org/10.1002/ibd.21338
Purine analog for the prevention of postoperative recurrence of Crohn's disease: Is it really better?
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 665–666, https://doi.org/10.1002/ibd.21340
Adalimumab for the treatment of fistulas in patients with Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 667–668, https://doi.org/10.1002/ibd.21343
Letters to the Editors
Hepatitis B reactivation in patients with inflammatory bowel disease: A prospective survey on screening and prevention practices at general hospitals in France
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 669–670, https://doi.org/10.1002/ibd.21276
Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 671–673, https://doi.org/10.1002/ibd.21289
Myeloproliferative disorders in patients with inflammatory bowel disease on anti-TNF-α therapy: Report of two cases and review of the literature
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 674–675, https://doi.org/10.1002/ibd.21291
Onset of severe perianal disease in Crohn's disease under treatment with infliximab: Successful treatment with adalimumab and setons drainage
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 676–678, https://doi.org/10.1002/ibd.21292
Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn's disease on infliximab
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Page 679, https://doi.org/10.1002/ibd.21321
Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages 680–681, https://doi.org/10.1002/ibd.21322
EBV hepatitis in a young Crohn's disease patient on prolonged remission with azathioprine
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Page E1, https://doi.org/10.1002/ibd.21278
Development of communicating hydrocephalus after infliximab infusion
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E2–E3, https://doi.org/10.1002/ibd.21296
Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E4–E5, https://doi.org/10.1002/ibd.21309
Single-port laparoscopic access for Crohn's disease complicated by enterocutaneous fistula
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E6–E7, https://doi.org/10.1002/ibd.21315
New desensitization regimen with mesalamine granules in a patient with ulcerative colitis and mesalamine intolerance
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E8–E9, https://doi.org/10.1002/ibd.21323
Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Page E10, https://doi.org/10.1002/ibd.21324
Risk factors for colectomy in ulcerative colitis patients with severe flare-up: Some of the few things comparable between the US and Central Europe
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E11–E12, https://doi.org/10.1002/ibd.21350
Positive finding of colonic polymerase chain reaction for cytomegalovirus DNA is not false positive but a warning for treating patients with ulcerative colitis refractory to immunosuppressive therapies
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E13–E14, https://doi.org/10.1002/ibd.21401
Use of biologics in inflammatory bowel disease patients with cirrhosis
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E15–E16, https://doi.org/10.1002/ibd.21434
Severe neutropenia following infliximab treatment in a child with ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E17–E18, https://doi.org/10.1002/ibd.21466
Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E19–E21, https://doi.org/10.1002/ibd.21470
Rapid increase in the prevalence of inflammatory bowel disease in candidates for the military service born after 1988 in Korea
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Page E22, https://doi.org/10.1002/ibd.21474
Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability
Inflammatory Bowel Diseases, Volume 17, Issue 2, 1 February 2011, Pages E23–E25, https://doi.org/10.1002/ibd.21588
